Aptitude Metrix COVID-19 Test (25/bx)

• PCR-quality results in a box
• Fast results in just 30 minutes
• Results are analyzed and displayed by the Metrix Reader
• Allows nasal swabs or saliva for convenience
• Authorized by the FDA under an EUA, pending FDA clearance / approval
• Authorized for non-prescription home use
• CLIA waived
• Shelf life: 18 months .

The Sekisui Aptitude Metrix COVID-19 Test is designed for easy, efficient, and accessible detection of COVID-19 in just 30 minutes anytime, anywhere. It has the sensitivity and specificity of a PCR and the speed of a rapid test, enabling the early detection, treatment, and containment of COVID-19 even before symptoms show.

Simple 3-Step Process:

Accurate Results the First Time: Unlike antigen tests that must be performed multiple days in a row due to the risk of erroneous results, the Metrix COVID-19 Test provides accurate results the first time. No more multiple tests, just confidence on the first go. This reduces costs, ensures early detection, and stops the spread of infection.

Unmatched Sensitivity: Metrix outperforms antigen tests in detecting COVID early, with nasal swabs showing 97% sensitivity vs. PCR without multiple tests. It also provides molecular precision to minimize false alarms, with nasal swabs showing 99% specificity compared to PCR.

Flexible Sampling: Use nasal swab when accuracy is essential, and saliva when increased accessibility is needed.

Eco-Friendly: Metrix COVID-19 Tests are analyzed by the Metrix Reader (sold separately), a reusable device that does not have to be thrown away after each use

Available Options

The Metrix COVID-19 Test is available in the following packages:

• MTRX-C19-25PK: 25x Metrix COVID-19 Tests

• MTRX-C19-B1: Bundle: 1 Metrix Reader + 50 Metrix COVID-19 Tests

With the Aptitude Metrix COVID-19 Test, at-home patients and point-of-care medical professionals can detect infections days ahead compared with other tests, increasing the chances of recovery and prevention of spreading.

FDA Disclaimers:

• This test is not FDA-cleared or approved.
• It has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories.
• It has been authorized only for the detection of proteins from SARS-CoV-2 and not for any other viruses or pathogens.
• This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for the detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) unless the authorization is terminated or revoked sooner.

WARNING: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.